Drug Trial Radar · NCT06523400
The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2
Last checked: Nov 20, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
176
Planned (sponsor's estimate)
Start
Feb 13, 2025
Primary completion
Jun 2027
Study completion Jun 2027
Sponsor
- Lead sponsor
- Lupin Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- Lupin Atlantis Holdings S.A.
- First posted
- Jul 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Investigate the Efficacy and Safety of Once Daily Mexiletine PR During 26 Weeks of Treatment in Patients with Myotonic Dystrophy Type 1 and Type 2 (HERCULES study) Study website: https://myotonicdystrophystudy.com/
Conditions
- Myotonic Dystrophy
Interventions
Mexiletine granules for prolonged-release oral suspensionDrug
Mexiletine PR
PlaceboDrug
Matching Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the efficacy of once daily mexiletine PR for the symptomatic treatment of myotonia in patients with myotonic dystrophy type 1 and type 2 (DM1 and DM2).Time frame: 26 weeks
Locations
7 sites in 6 countries. Site status is shown where the registry gives one.
Laboratory for Muscle Diseases and Neuropathies
Leuven, Belgium · Recruiting
Aarhus University Hospital
Aarhus, Denmark · Recruiting
Ludug-Maximilians University
München, Germany · Recruiting
Azienda Ospedaliera Universitaria Policlinico Tor Vergata
Rome, Italy · Recruiting
University Hospital of Madrid
Madrid, Spain · Recruiting
Saint George's University Hospitals NHS Foundation Trust
London, United Kingdom · Recruiting
University College Hospital
London, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.